Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy

Overview

Journal Case Rep Obstet Gynecol

Publisher Wiley

Specialty Gynecology & Obstetrics

Date 2015 Sep 29

PMID 26413360

Citations 7

Authors

Karoline Mayer-Pickel

Sabine Horn

Uwe Lang

Mila Cervar-Zivkovic

Affiliations

Soon will be listed here.

Abstract

An imbalance of angiogenic and antiangiogenic placental factors such as endoglin and soluble fms-like tyrosine kinase 1 has been implicated in the pathophysiology of preeclampsia. Extraction of these substances by plasmapheresis might be a therapeutical approach in cases of severe early-onset preeclampsia. Case Report. A 21-year-old primigravida with antiphospholipid syndrome developed early-onset preeclampsia at 18 weeks' gestation. She was treated successfully with plasmapheresis in order to prolong pregnancy. Endoglin and sflt-1-levels were measured by ELISA before and after treatment. Endoglin levels decreased significantly after treatment (p < 0.05) and showed a significant decrease throughout pregnancy. A rerise of endoglin and sflt-1 preceded placental abruption 4 weeks before onset of incident. Conclusion. Due to the limited long-term therapeutical possibilities for pregnancies complicated by PE, plasmapheresis seems to be a therapeutical option. This consideration refers especially to pregnancies with early-onset preeclampsia, in which, after first conventional treatment of PE, prolongation of pregnancy should be above all.

Citing Articles

Therapeutic Plasma Exchange in Early-Onset Preeclampsia: A 7-Year Monocentric Experience.

Iannaccone A, Reisch B, Kimmig R, Schmidt B, Mavarani L, Oppong M J Clin Med. 2023; 12(13).

PMID: 37445324 PMC: 10342637. DOI: 10.3390/jcm12134289.

Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report.

Cottrell J, Al Sanani A, Ogu I, Chaffin D Transfus Med Hemother. 2023; 50(2):154-158.

PMID: 37066051 PMC: 10091001. DOI: 10.1159/000526349.

Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature.

Hoxha A, Tormene D, Campello E, Simioni P Front Pharmacol. 2022; 13:849692.

PMID: 35662738 PMC: 9160870. DOI: 10.3389/fphar.2022.849692.

What's new in obstetric antiphospholipid syndrome.

Branch D Hematology Am Soc Hematol Educ Program. 2019; 2019(1):421-425.

PMID: 31808896 PMC: 6913435. DOI: 10.1182/hematology.2019000043.

Idiopathic Normal Pressure Hydrocephalus - What We Know.

Baltatanu D, Berteanu M Maedica (Bucur). 2019; 14(2):161-164.

PMID: 31523298 PMC: 6709400. DOI: 10.26574/maedica.2019.14.2.161.

References

Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim Y . Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006; 12(6):642-9. DOI: 10.1038/nm1429. View

Rana S, Karumanchi S, Levine R, Venkatesha S, Rauh-Hain J, Tamez H . Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007; 50(1):137-42. DOI: 10.1161/HYPERTENSIONAHA.107.087700. View

Wang Y, Walli A, Schulze A, Blessing F, Fraunberger P, Thaler C . Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia. Transfus Apher Sci. 2006; 35(2):103-10. DOI: 10.1016/j.transci.2006.05.010. View

Duff S, Li C, Garland J, Kumar S . CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 2003; 17(9):984-92. DOI: 10.1096/fj.02-0634rev. View

Bontadi A, Ruffatti A, Marson P, Tison T, Tonello M, Hoxha A . Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome. J Clin Apher. 2012; 27(4):200-4. DOI: 10.1002/jca.21229. View

Raab U, Lastres P, Arevalo M, Lopez-Novoa J, Cabanas C, de la Rosa E . Endoglin is expressed in the chicken vasculature and is involved in angiogenesis. FEBS Lett. 1999; 459(2):249-54. DOI: 10.1016/s0014-5793(99)01252-1. View

Shenkman B, Einav Y . Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Autoimmun Rev. 2014; 13(4-5):584-6. DOI: 10.1016/j.autrev.2014.01.004. View

Rosenberg V, Buhimschi I, Lockwood C, Paidas M, Dulay A, Ramma W . Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy. Circulation. 2011; 124(23):2543-53. DOI: 10.1161/CIRCULATIONAHA.111.046821. View

Jeyabalan A, McGonigal S, Gilmour C, Hubel C, Rajakumar A . Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta. 2008; 29(6):555-63. PMC: 2467513. DOI: 10.1016/j.placenta.2008.03.006. View

10.

St-Jacques S, Forte M, Lye S, Letarte M . Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod. 1994; 51(3):405-13. DOI: 10.1095/biolreprod51.3.405. View

11.

Bortolati M, Marson P, Chiarelli S, Tison T, Facchinetti M, Gervasi M . Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome. Ther Apher Dial. 2009; 13(2):157-60. DOI: 10.1111/j.1744-9987.2009.00671.x. View

12.

Carroll T, Mulla M, Han C, Brosens J, Chamley L, Giles I . Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin. Am J Reprod Immunol. 2011; 66(4):286-96. DOI: 10.1111/j.1600-0897.2011.01007.x. View

13.

Bosch T . Therapeutic apheresis--state of the art in the year 2005. Ther Apher Dial. 2005; 9(6):459-68. DOI: 10.1111/j.1744-9987.2005.00306.x. View

14.

Jin F, Cao M, Bai Y, Zhang Y, Yang Y, Zhang B . Therapeutic effects of plasma exchange for the treatment of 39 patients with acute fatty liver of pregnancy. Discov Med. 2012; 13(72):369-73. View

15.

Ruffatti A, Marson P, Pengo V, Favaro M, Tonello M, Bortolati M . Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun Rev. 2007; 6(3):196-202. DOI: 10.1016/j.autrev.2006.11.002. View

16.

Raab U, Velasco B, Lastres P, Letamendia A, Cales C, Langa C . Expression of normal and truncated forms of human endoglin. Biochem J. 1999; 339 ( Pt 3):579-88. PMC: 1220193. View

17.

Redman C, Sargent I . Latest advances in understanding preeclampsia. Science. 2005; 308(5728):1592-4. DOI: 10.1126/science.1111726. View

18.

Stepan H, Kramer T, Faber R . Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab. 2007; 92(7):2831-4. DOI: 10.1210/jc.2006-2774. View

19.

Martin Jr J, Perry Jr K, Roberts W, Norman P, Files J, Blake P . Plasma exchange for preeclampsia: II. Unsuccessful antepartum utilization for severe preeclampsia with or without HELLP syndrome. J Clin Apher. 1994; 9(3):155-61. DOI: 10.1002/jca.2920090302. View

20.

Reddy A, Suri S, Sargent I, Redman C, Muttukrishna S . Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PLoS One. 2009; 4(2):e4453. PMC: 2675175. DOI: 10.1371/journal.pone.0004453. View